Interpace Biosciences (IDXG)
(Delayed Data from OTC)
$1.40 USD
+0.14 (11.11%)
Updated Jun 14, 2024 03:48 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Interpace Biosciences, Inc. [IDXG]
Reports for Purchase
Showing records 21 - 40 ( 63 total )
Company: Interpace Biosciences, Inc.
Industry: Medical Services
ThyGeNEXT Draft Medicare Reimbursement Rate Rises 380%; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Thyroid Test Utility Data Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
New Data Support Clinical Utility of PancraGEN; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Company: Interpace Biosciences, Inc.
Industry: Medical Services
New In-Network Contracts with Blue Cross Blue Shield; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
China BioPharma Services Partnership Inked; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Thyroid Testing Now In-Network in Michigan; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Thyroid Testing In-Network Status Expanded in California; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Thyroid Testing Expands Coverage in Utah and Idaho; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Bringing AI to Thyroid Cancer Diagnosis and Therapy; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Cancer Genetics Biopharma Services Business Acquired; Reiterate Buy; Lowering Price Target to $2 Based on Dilution
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Thyroid Testing Expands Coverage in Pennsylvania; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: CHEN Y
Company: Interpace Biosciences, Inc.
Industry: Medical Services
1Q19 Financial Results Reported; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Thyroid Tests'' Clinical Utility Data Published; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Interpace Biosciences, Inc.
Industry: Medical Services
ThyraMIR Obtains New York State Approval; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Interpace Biosciences, Inc.
Industry: Medical Services
New Coverage of Thyroid Tests by Medica; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Interpace Biosciences, Inc.
Industry: Medical Services
2018 Financial Results Reported; Reiterate Buy; Raising Price Target to $3.50
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R
Company: Interpace Biosciences, Inc.
Industry: Medical Services
Preliminary 2018 Revenue Shows 38% Growth; Reiterate Buy
Provider: H.C. Wainwright & Co., Inc.
Analyst: SELVARAJU R